BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34328205)

  • 1. [Mortality in patients with intracerebral haemorrhage associated with oral anticoagulation. Efficacy of a reversal protocol and clinical follow-up (ICH-OAC project)].
    Amores-Valenciano P; Ruiz Escribano-Taravilla E; Romero-Sánchez CM; Prado-Mira A; García-Gil E; Espejo-López AB; Collado-Jiménez RM; Molina-Nuevo JD; Marín-Sánchez A; Hernández-Fernández F
    Rev Neurol; 2021 Sep; 73(5):165-173. PubMed ID: 34328205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use.
    Seiffge DJ; Goeldlin MB; Tatlisumak T; Lyrer P; Fischer U; Engelter ST; Werring DJ
    J Neurol; 2019 Dec; 266(12):3126-3135. PubMed ID: 31541341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
    Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.
    Horstmann S; Rizos T; Lauseker M; Möhlenbruch M; Jenetzky E; Hacke W; Steiner T; Veltkamp R
    J Neurol; 2013 Aug; 260(8):2046-51. PubMed ID: 23645221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry.
    Gabriele F; Foschi M; Conversi F; Ciuffini D; De Santis F; Orlandi B; De Santis F; Ornello R; Sacco S
    Int J Stroke; 2024 Jun; 19(5):515-525. PubMed ID: 37997897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
    Kuramatsu JB; Gerner ST; Schellinger PD; Glahn J; Endres M; Sobesky J; Flechsenhar J; Neugebauer H; Jüttler E; Grau A; Palm F; Röther J; Michels P; Hamann GF; Hüwel J; Hagemann G; Barber B; Terborg C; Trostdorf F; Bäzner H; Roth A; Wöhrle J; Keller M; Schwarz M; Reimann G; Volkmann J; Müllges W; Kraft P; Classen J; Hobohm C; Horn M; Milewski A; Reichmann H; Schneider H; Schimmel E; Fink GR; Dohmen C; Stetefeld H; Witte O; Günther A; Neumann-Haefelin T; Racs AE; Nueckel M; Erbguth F; Kloska SP; Dörfler A; Köhrmann M; Schwab S; Huttner HB
    JAMA; 2015 Feb; 313(8):824-36. PubMed ID: 25710659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists.
    Alonso de Leciñana M; Huertas N; Egido JA; Muriel A; García A; Ruiz-Ares G; Díez-Tejedor E; Fuentes B
    Thromb Haemost; 2013 Dec; 110(6):1145-51. PubMed ID: 24030842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
    Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R
    JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage.
    Kuramatsu JB; Sembill JA; Huttner HB
    Crit Care; 2019 Jun; 23(1):206. PubMed ID: 31171018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation patients who sustained warfarin-associated intracerebral haemorrhage have poor neurological outcomes: results from a matched case series.
    Fong MK; Sheng B; Chu YP; Wong WT; Lau PP; Wong HY; Lau KK
    Hong Kong Med J; 2017 Apr; 23(2):117-21. PubMed ID: 28232641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Intracerebral Hemorrhage Related to Antithrombotic Use: An Observational Study From the Swedish Stroke Register (Riksstroke).
    Apostolaki-Hansson T; Ullberg T; Pihlsgård M; Norrving B; Petersson J
    Stroke; 2021 Mar; 52(3):966-974. PubMed ID: 33563019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.
    Curtze S; Strbian D; Meretoja A; Putaala J; Eriksson H; Haapaniemi E; Mustanoja S; Sairanen T; Satopää J; Silvennoinen H; Niemelä M; Kaste M; Tatlisumak T
    Eur J Neurol; 2014 Apr; 21(4):616-22. PubMed ID: 24447727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.
    Lioutas VA; Goyal N; Katsanos AH; Krogias C; Zand R; Sharma VK; Varelas P; Malhotra K; Paciaroni M; Sharaf A; Chang J; Karapanayiotides T; Kargiotis O; Pappa A; Mai J; Pandhi A; Schroeder C; Tsantes A; Mehta C; Kerro A; Khan A; Mitsias PD; Selim MH; Alexandrov AV; Tsivgoulis G
    Stroke; 2018 Oct; 49(10):2309-2316. PubMed ID: 30355114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage.
    Sprügel MI; Sembill JA; Kuramatsu JB; Gerner ST; Hagen M; Roeder SS; Endres M; Haeusler KG; Sobesky J; Schurig J; Zweynert S; Bauer M; Vajkoczy P; Ringleb PA; Purrucker JC; Rizos T; Volkmann J; Muellges W; Kraft P; Schubert AL; Erbguth F; Nueckel M; Schellinger PD; Glahn J; Knappe UJ; Fink GR; Dohmen C; Stetefeld H; Fisse AL; Minnerup J; Hagemann G; Rakers F; Reichmann H; Schneider H; Wöpking S; Ludolph AC; Stösser S; Neugebauer H; Röther J; Michels P; Schwarz M; Reimann G; Bäzner H; Schwert H; Classen J; Michalski D; Grau A; Palm F; Urbanek C; Wöhrle JC; Alshammari F; Horn M; Bahner D; Witte OW; Guenther A; Hamann GF; Lücking H; Dörfler A; Schwab S; Huttner HB
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):783-791. PubMed ID: 30992334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage.
    Tsivgoulis G; Wilson D; Katsanos AH; Sargento-Freitas J; Marques-Matos C; Azevedo E; Adachi T; von der Brelie C; Aizawa Y; Abe H; Tomita H; Okumura K; Hagii J; Seiffge DJ; Lioutas VA; Traenka C; Varelas P; Basir G; Krogias C; Purrucker JC; Sharma VK; Rizos T; Mikulik R; Sobowale OA; Barlinn K; Sallinen H; Goyal N; Yeh SJ; Karapanayiotides T; Wu TY; Vadikolias K; Ferrigno M; Hadjigeorgiou G; Houben R; Giannopoulos S; Schreuder FHBM; Chang JJ; Perry LA; Mehdorn M; Marto JP; Pinho J; Tanaka J; Boulanger M; Al-Shahi Salman R; Jäger HR; Shakeshaft C; Yakushiji Y; Choi PMC; Staals J; Cordonnier C; Jeng JS; Veltkamp R; Dowlatshahi D; Engelter ST; Parry-Jones AR; Meretoja A; Mitsias PD; Alexandrov AV; Ambler G; Werring DJ
    Ann Neurol; 2018 Nov; 84(5):694-704. PubMed ID: 30255970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
    Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
    Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.